Astellas Pharma, Inc. (ALPMF) Q1 2022 Results – Earnings Call Transcript

Astellas Pharma, Inc. (OTCPK:ALPMF) Q1 2022 Results Conference Call July 30, 2021 3:00 AM ET
Company Participants
Naoki Okamura – CSO & CFO
Mike Kitagawa – Senior VP of Development Project Management
Yukio Matsui – Chief Commercial Officer
Conference Call…

Click here to view the original article.